全文获取类型
收费全文 | 305篇 |
免费 | 19篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 31篇 |
妇产科学 | 2篇 |
基础医学 | 13篇 |
口腔科学 | 13篇 |
临床医学 | 26篇 |
内科学 | 95篇 |
皮肤病学 | 5篇 |
神经病学 | 15篇 |
特种医学 | 7篇 |
外科学 | 65篇 |
综合类 | 5篇 |
预防医学 | 8篇 |
眼科学 | 5篇 |
药学 | 16篇 |
肿瘤学 | 8篇 |
出版年
2023年 | 1篇 |
2022年 | 4篇 |
2021年 | 10篇 |
2020年 | 7篇 |
2019年 | 13篇 |
2018年 | 13篇 |
2017年 | 5篇 |
2016年 | 12篇 |
2015年 | 10篇 |
2014年 | 20篇 |
2013年 | 16篇 |
2012年 | 24篇 |
2011年 | 12篇 |
2010年 | 9篇 |
2009年 | 11篇 |
2008年 | 20篇 |
2007年 | 21篇 |
2006年 | 25篇 |
2005年 | 20篇 |
2004年 | 17篇 |
2003年 | 14篇 |
2002年 | 18篇 |
2001年 | 6篇 |
2000年 | 4篇 |
1999年 | 3篇 |
1997年 | 3篇 |
1996年 | 2篇 |
1995年 | 2篇 |
1994年 | 1篇 |
1993年 | 1篇 |
1989年 | 1篇 |
排序方式: 共有325条查询结果,搜索用时 15 毫秒
321.
Onur Armagan Dilek Kaya Serin C��neyt Calisir Ali Dokumacioglu Merih Ozgen Setenay Oner Ozkan Alatas 《Journal of Korean medical science》2012,27(11):1405-1410
This study was conducted to determine if nasal salmon calcitonin has additional beneficial effects on clinical symptoms, serum NO, IL-1β, matrix metalloproteinase 3, urinary C-terminal telopeptide type II collagen (CTX-II) levels and MRI findings in knee osteoarthritis (OA) when used concomitantly with exercise therapy. Fifty female patients with knee OA were randomized into two groups. The first group (n = 30) received 200 IU/day nasal salmon calcitonin and a home exercise program; the second group (n = 20) received a home exercise program for 6 months. Compared with baseline,while significant improvements were observed in visual analogue scale (VAS), WOMAC pain, physical function scores, 20-m walking time (P < 0.001) and WOMAC stiffness score (P = 0.041) in the first group, walking and resting VAS, and WOMAC physical function scores were improved (P = 0.029) in the second group after treatment. Significantly increased levels of serum NO and urinary CTX-II (P < 0.001) and significant improvements in the area of medial femoral condyle (P < 0.05) were noted only in the first group. There were significant differences in VAS activation values (P = 0.032) and NO levels (P < 0.001) in the favor of the first group. In conclusion, nasal salmon calcitonin may have possible chondroprotective effects besides its known effects on symptoms in patients with knee OA. 相似文献
322.
Armagan Tugrul Sibel Guldiken Betul Ugur-Altun Ender Arikan 《Yonsei medical journal》2009,50(2):195-199
Purpose
This study aimed to determine the impaired glucose tolerance and diabetes prevalence in patients with essential hypertension (HT) and to compare the developed microvascular complications of these groups.Materials and Methods
An oral glucose tolerance test (OGTT) was performed on 338 essential hypertensive cases and glucose tolerances were classified according to ADA-2002 criteria.Results
Of the 338 cases, 32 people had diabetes (DM, 9.46%), 78 people had glucose intolerance (IGT, 23.1%), and 228 people had only hypertension but not IGT and DM (67.4%). Both the mean ages of the DM group (56.9 ± 6.7 years, p = 0.002) and IGT group (56.3 ± 8.4 years, p = 0.003) were older than the mean age of the control group (51.1 ± 6.4 years). The risk of IGT development was found to be four times greater in male cases than female cases when compared to the control group (p = 0.004, add ratio = 4.194). There were no significant differences in the body mass indexes (BMI''s), hypertension durations, and microvascular complications between the groups.Conclusion
In conclusion, the risk of IGT and DM development in hypertensive cases increases with aging and longer hypertension duration. The risk of IGT development in hypertensive cases is four times more in males. 相似文献323.
324.
Ozcan T Cin VG Yurtdas M Akcay B Seyis S Acele A Cicek D Camsari A Akkus N Doven O 《International heart journal》2007,48(1):11-23
OBJECTIVES: To investigate the late outcomes of sirolimus-eluting stent implantation in patients with coronary artery disease. BACKGROUND: Drug-eluting stents reduce intimal hyperplasia, which is the main cause of in-stent restenosis. Sirolimus-eluting stents significantly reduce clinical and angiographic restenosis and improve event-free survival. METHODS: The study population consisted of 207 patients (273 stents) who had undergone coronary Cypher stent implantation. Patients were eligible for enrollment if there was symptomatic coronary artery disease or positive exercise testing, and angiographic evidence of single or multivessel disease with a target lesion stenosis of > or = 70% in a > or = 2.25 mm vessel. Follow-up coronary angiography was performed 18 months after stent deployment. Patients were followed-up for a mean of 24.7 +/- 7.4 months. RESULTS: All patients survived after stent implantation, but 5 (2.4%) patients experienced acute ST elevation myocardial infarction and 4 (1.9%) patients developed non-Q wave myocardial infarction following angioplasty. Recurrent angina pectoris was observed in 16 (7.7%) patients (11 stable angina pectoris and 5 unstable angina pectoris). Angiographic evidence of restenosis was observed in these 20 (9.66%) patients. The 5 other patients had noncritical angiographic restenosis. Eleven (5.3%) patients underwent angioplasty because of restenosis, and coronary artery bypass grafting was conducted in the other 9 (4.3%) patients. CONCLUSION: The results of the present study indicate that Cypher stents could be implanted with a very high success rate and have encouraging long-term angiographic and clinical results. 相似文献
325.